These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18243842)

  • 41. Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
    Lui WY; Liu RS; Chiang JH; Lo JG; Lai KH; King KL; Cheng HC; Wei YY; Chi CW; P'eng FK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):125-33. PubMed ID: 2178041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
    Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer.
    Nakajo M; Kobayashi H; Shimabukuro K; Shirono K; Sakata H; Taguchi M; Uchiyama N; Sonoda T; Shinohara S
    J Nucl Med; 1988 Jun; 29(6):1066-77. PubMed ID: 2836573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
    Raoul JL; Boucher E; Roland V; Garin E
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re: 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report.
    London L
    Ann Acad Med Singap; 2002 Jan; 31(1):132. PubMed ID: 11885488
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
    Luo TY; Shih YH; Chen CY; Tang IC; Wu YL; Kung HC; Lin WJ; Lin XZ
    Cancer Biother Radiopharm; 2009 Oct; 24(5):535-41. PubMed ID: 19877883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How I treat... An hepatocellular carcinoma: role of selective internal radiation therapy with intra-arterial iodine-131].
    Werenne X
    Rev Med Liege; 2007 Oct; 62(10):603-6. PubMed ID: 18069570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC; Luo TY; Liu SW; Chan SH; Kung HC; Peng CL; Lin WY; Chang Y; Lin WJ
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol)].
    Kajiya Y; Nakajo M; Kobayashi H; Oyama T; Shinohara S
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):815-21. PubMed ID: 2849622
    [No Abstract]   [Full Text] [Related]  

  • 51. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma.
    Meléndez-Alafort L; Nadali A; Zangoni E; Banzato A; Rondina M; Rosato A; Mazzi U
    Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
    Madsen MT; Park CH; Thakur ML
    J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
    Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
    Bal CS; Kumar A
    Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device--a first-in-man study.
    Goh AS; Chung AY; Lo RH; Lau TN; Yu SW; Chng M; Satchithanantham S; Loong SL; Ng DC; Lim BC; Connor S; Chow PK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):786-92. PubMed ID: 17141975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat.
    Garin E; Denizot B; Roux J; Noiret N; Lepareur N; Moreau M; Mesba H; Laurent JF; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
    Lab Anim; 2005 Jul; 39(3):314-20. PubMed ID: 16004691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosimetric evaluation and therapeutic response to internal radiation therapy of hepatocarcinomas using iodine-131-labelled lipiodol.
    Becker S; Laffont S; Vitry F; Rolland Y; Lecloirec J; Boucher E; Raoul JL; Herry JY; Bourguet P; Garin E
    Nucl Med Commun; 2008 Sep; 29(9):815-25. PubMed ID: 18677210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.